Fonar ROE 2006-2018 | FONR

Current and historical return on equity (ROE) values for Fonar (FONR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Fonar ROE for the three months ending December 31, 2018 was 18.40%.
Fonar ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.02B $0.11B 17.48%
2018-09-30 $0.02B $0.11B 19.39%
2018-06-30 $0.02B $0.10B 20.49%
2018-03-31 $0.02B $0.09B 18.18%
2017-12-31 $0.02B $0.09B 22.75%
2017-09-30 $0.02B $0.09B 24.28%
2017-06-30 $0.02B $0.08B 25.94%
2017-03-31 $0.02B $0.08B 28.04%
2016-12-31 $0.02B $0.07B 25.20%
2016-09-30 $0.02B $0.07B 24.90%
2016-06-30 $0.02B $0.06B 26.32%
2016-03-31 $0.01B $0.06B 25.69%
2015-12-31 $0.01B $0.06B 25.12%
2015-09-30 $0.01B $0.05B 23.88%
2015-06-30 $0.01B $0.05B 22.45%
2015-03-31 $0.01B $0.05B 20.94%
2014-12-31 $0.01B $0.05B 21.39%
2014-09-30 $0.01B $0.05B 22.35%
2014-06-30 $0.01B $0.05B 23.39%
2014-03-31 $0.01B $0.04B 24.54%
2013-12-31 $0.01B $0.04B 23.23%
2013-09-30 $0.01B $0.04B 25.20%
2013-06-30 $0.01B $0.04B 28.00%
2013-03-31 $0.00B $0.04B 21.92%
2012-12-31 $0.00B $0.01B 32.65%
2012-09-30 $0.00B $0.01B 36.36%
2012-06-30 $0.00B $0.01B 42.11%
2012-03-31 $0.00B $0.01B 36.36%
2011-12-31 $0.00B $0.01B 57.14%
2011-09-30 $0.00B $0.01B 150.00%
2011-06-30 $0.00B $0.01B -200.00%
2011-03-31 $0.00B $-0.00B -50.00%
2010-12-31 $0.00B $-0.00B -19.05%
2010-09-30 $-0.00B $-0.01B 17.39%
2010-06-30 $-0.00B $-0.01B 52.17%
2010-03-31 $-0.00B $-0.01B 60.00%
2009-12-31 $-0.00B $-0.01B 47.06%
2009-09-30 $0.00B $-0.01B 0.00%
2009-06-30 $0.00B $-0.00B -53.33%
2009-03-31 $-0.01B $-0.00B 125.00%
2008-12-31 $-0.01B $-0.00B 360.00%
2008-09-30 $-0.01B $-0.01B 5600.00%
2008-06-30 $-0.01B $-0.00B -430.77%
2008-03-31 $-0.02B $0.00B -246.15%
2007-12-31 $-0.02B $0.01B -180.00%
2007-09-30 $-0.02B $0.01B -131.03%
2007-06-30 $-0.03B $0.01B -129.87%
2007-03-31 $-0.03B $0.02B -102.04%
2006-12-31 $-0.03B $0.02B -90.76%
2006-09-30 $-0.03B $0.03B -77.14%
2006-06-30 $-0.03B $0.03B -72.96%
2006-03-31 $-0.02B $0.04B -44.20%
2005-12-31 $-0.01B $0.04B -26.67%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.137B $0.082B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29